Phase 2 study of CHOP‑R‑14 followed by 90Y‑ibritumomab tiuxetan in patients with previously untreated diffuse large B‑cell lymphoma
Karmali, Reem, Larson, Melissa, Shammo, Jamile, Gregory, Stephanie, O'brien, Teresa, Venugopal, ParameswaranМова:
english
Журнал:
Molecular and Clinical Oncology
DOI:
10.3892/mco.2017.1169
Date:
February, 2017
Файл:
PDF, 337 KB
english, 2017
File converter
Більше результатів пошуку
More benefits 
